Drawing for XPHE

USPTO serial 79237119

XPHE

Reviewed by CopyMark Law Group

Reg. 5980122Status 706Registered
Filing date
Status date
Registration date
Feb 11, 2020
Examiner
LIU, PHILIP
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with XPHE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patrick F. Clunk

Patrick F. Clunk Tucker Ellis LLP950 Main Ave. Suite 1100Cleveland, OH 44113United States

Goods and services

ClassDescriptionStatusFirst use
005Amino acids for medical purposes, separately or in combination; balanced supplementary dietetic products and balanced supplementary dietetic products, namely, dietetic foods for special medical purposes adapted for the treatment of phenylketonuria; dietetic products for medical purposes, namely, foodstuffs, food supplements and beverages adapted for medical purposes; dietetic substances, namely, protein supplements, vitamin supplements, mineral supplements, dietary supplements, and food supplements for medical purposes; dietetic foods adapted for medical purposes; protein-based products, namely, dietary supplements and dietetic products in the nature of dietetic foods adapted for medical purposes containing modified milk proteins, modified proteins of vegetable and animal origin, biotechnologically produced proteins and recombinant dietary proteins for medical purposes; protein-based food supplements for medical purposes with the addition of amino acids, carbohydrates, lipids, vitamins, minerals and trace elements [ ; diagnostic preparations for medical purposes; amino acids for veterinary purposes ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 22, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 22, 202671AGREGISTERED-SEC.71 ACCEPTED—
Sep 20, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 30, 2026ES71TEAS SECTION 71 RECEIVED—
Dec 4, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Feb 11, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 18, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 12, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 27, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 27, 2020FIMPFINAL DISPOSITION PROCESSED—
May 11, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 11, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 10, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 25, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 25, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 26, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 26, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2019GPNXNOTIFICATION PROCESSED BY IB—
Nov 6, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 6, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 6, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 18, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 30, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 30, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 30, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 22, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 22, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 22, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 20, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 20, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 19, 2019ALIEASSIGNED TO LIE—
Apr 12, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2018RFNTREFUSAL PROCESSED BY IB—
Oct 29, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 29, 2018RFRRREFUSAL PROCESSED BY MPU—
Oct 16, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 15, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2018DOCKASSIGNED TO EXAMINER—
Jul 28, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 24, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 19, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance